Auto Stem Cell Transplant for Lymphoma Patients

NCT03125642 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkin Lymphoma
Hodgkin Lymphoma

Interventions

DRUG: Etoposide
DRUG: BCNU
DRUG: AraC
DRUG: Melphalan
PROCEDURE: Peripheral blood stem cell transplantation
BIOLOGICAL: G-CSF
DRUG: Cyclophosphamide
RADIATION: Total Body Irradiation

Sponsor

Masonic Cancer Center, University of Minnesota